Wan Nadiah named group CEO of TMC Life Sciences

Wan Nadiah named group CEO of TMC Life Sciences

KUALA LUMPUR (Jan 23): Wan Nadiah Wan Mohd Abdullah Yaakob has been named as the group chief executive officer(CEO) of TMC Life Sciences Bhd, effective Feb 1.

The 34-year old is currently the CEO of Thomson Hospitals Sdn Bhd, a unit of TMC Life Sciences, and the group chief corporate officer of TMC Life Sciences whose flagship is the Thomson Hospital in Kota Damansara.

In separate filings to Bursa Malaysia, TMC Life Sciences also announced the resignation of its executive director Roy Quek Hong Sheng, 48, and its non independent and non executive director Freddie Heng Kim Chuan, 65, with effect from Jan 25.

Quek and Heng are both Singaporean nationals. The reason given for their resignation is that it was part of the Thomson Medical Group Ltd’s strategy to put in place strong local leadership, as it prepares for its next phase of rapid growth and development.

The group also announced the appointment of Barry Kan Kheong Ng, 63, as an executive director of TMC Life Sciences. Kan, a Malaysian, is a veteran of almost 30 years in the automotive industry, with rich and vast experience in managing various illustrious global brands during his career with renowned regional dealership, Wearnes Automotive, headquartered in Singapore. Prior to that, he was with the Port Authority of Singapore for seven years.

Meanwhile, TMC Life Sciences also announced the appointments of Dr George Lee Lam, 59, and Datuk Seri Mohd Mokhtar Mohd Shariff, 61, as independent and non-executive directors.

Lam, a Canadian national, is the chairman of the Hong Kong Cyberport Management Company Ltd, while Mohd Mokhtar was the former director of the Special Branch and Narcotics Crime Investigation Department.

Source: The Edge Markets